Pedigo NW Jr

First name:
Pedigo
Last name:
NW
Suffix:
Jr
Rowlett, J. K., NW, P., & Bardo, M. T. (1991). Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats. Pharmacology, Biochemistry, And Behavior, 40(4), 829-34. https://doi.org/10.1016/0091-3057(91)90093-h
View
Lauderback, C. M., Harris-White, M. E., Wang, Y., NW, P., Carney, J. M., & Butterfield, D. A. Amyloid beta-peptide inhibits Na+-dependent glutamate uptake. Life Sciences, 65(18-19), 1977-81. https://doi.org/10.1016/s0024-3205(99)00459-2 (Original work published 1999)
View
Butterfield, D. A., Howard, B., Yatin, S., Koppal, T., Drake, J., Hensley, K., et al. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sciences, 65(18-19), 1883-92. https://doi.org/10.1016/s0024-3205(99)00442-7 (Original work published 1999)
View
Harris, M. E., Wang, Y., NW, P., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996). Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. Journal Of Neurochemistry, 67(1), 277-86. https://doi.org/10.1046/j.1471-4159.1996.67010277.x
View
Harris, M. E., Carney, J. M., Cole, P. S., Hensley, K., Howard, B. J., Martin, L., et al. (1995). beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport, 6(14), 1875-9. https://doi.org/10.1097/00001756-199510020-00013 (Original work published 1995)
View